Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder
1 other identifier
interventional
90
1 country
1
Brief Summary
The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2022
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2025
CompletedSeptember 22, 2025
October 1, 2024
3.2 years
July 30, 2024
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Physical activity tracker adherence
Days (percentage) in which activity tracker was used (day-time and night-time use)
Treatment duration (4 weeks)
Physical activity tracker perceived utility
Perceived utility with the physical activity tracker will be assessed using ad-hoc questions about the utility of the activity tracker to increase levels of physical activity, improve sleep quality, and reduce/abandon tobacco.
End-of-treatment (4 weeks)
Physical activity levels
Physical activity (PA) is operationalized as steps per day, plants climbed per day, distance covered per day (kilometers), light physical activity (minutes per day), moderate physical activity (minutes per week), vigorous physical activity (minutes per week), and sedentary time (hours per day). These outcomes will be measured using an adapted version of the International Physical Activity Questionnaire (IPAQ) and Fitbit Versa 3®.
In-treatment (4 weeks), from enrollment to end-of treatment (4 weeks)
Depression symptoms
Depression symptoms will be measured using the Patient Health Questionnaire-9 (PHQ-9). This questionnaire ranges from 0 to 14. A higher punctuation means higher depression symptom levels.
From enrollment to the end-of-treatment (4 weeks)
Anxiety symptoms
Anxiety symptoms will be measured using Generalized Anxiety Disorder-7 (GAD-7). This questionnaire ranges from 0 to 21. Higher punctuation means higher anxiety levels symptoms.
From enrollment to the end-of-treatment (4 weeks)
Difficulties in emotion regulation
Emotion dysregulation is measured using the Difficulties in Emotion Regulation Scale (DERS). Emotional dysregulation of negative emotions is measured with the Difficulties in Emotion Regulation Scale (DERS). This scale ranges from 28 to 140 points. A higher score means more difficulties in emotion regulation.
From enrollment to the end-of-treatment (4 weeks)
Physical activity tracker acceptability
Acceptability of the activity tracker is measured using the Participant Experience Questionnaire (PEQ). This scale ranges from 10 to 50 points. A higher score means higher acceptability.
End-of-treatment (4 weeks)
Sleep quality
Sleep quality will be measured using both the Pittsburg Sleep Quality Index (PSQI) and the Fitbit Versa 3. PSQI ranges from 0 to 21 points. A higher score means lower sleep quality. In addition, Fitbit Versa 3 provides a sleep quality punctuation ranging from 0 to 100. A higher punctuation means better sleep quality.
In-treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)
Secondary Outcomes (2)
Tobacco use
In treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)
Delay discounting (impulsive decision making)
From enrollment to the end-of-treatment (4 weeks)
Study Arms (2)
Alcohol use disorder treatment plus Fitbit Versa 3
EXPERIMENTALParticipants will receive in-patient treatment for alcohol use disorder plus an activity tracker
Alcohol use disorder treatment
ACTIVE COMPARATORParticipants will receive in-patient treatment for alcohol use disorder
Interventions
Fitbit Versa 3 is a commercially available activity tracker
In-patient alcohol use disorder treatment, including group therapy, counseling, and occupational activities
Eligibility Criteria
You may qualify if:
- Being 18 years old or older.
- Be undergoing inpatient treatment for alcohol use disorder.
You may not qualify if:
- Finishing the treatment before 4 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Therapeutical community "La Santina"
Gijón, Principality of Asturias, 33394, Spain
Related Publications (4)
Scott CK, Dennis ML, Gustafson DH. Reprint of Using ecological momentary assessments to predict relapse after adult substance use treatment. Addict Behav. 2018 Aug;83:116-122. doi: 10.1016/j.addbeh.2018.04.003. Epub 2018 Apr 7.
PMID: 29661655BACKGROUNDPurani H, Friedrichsen S, Allen AM. Sleep quality in cigarette smokers: Associations with smoking-related outcomes and exercise. Addict Behav. 2019 Mar;90:71-76. doi: 10.1016/j.addbeh.2018.10.023. Epub 2018 Oct 17.
PMID: 30368021BACKGROUNDBrickwood KJ, Watson G, O'Brien J, Williams AD. Consumer-Based Wearable Activity Trackers Increase Physical Activity Participation: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth. 2019 Apr 12;7(4):e11819. doi: 10.2196/11819.
PMID: 30977740BACKGROUNDAbrantes AM, Blevins CE, Battle CL, Read JP, Gordon AL, Stein MD. Developing a Fitbit-supported lifestyle physical activity intervention for depressed alcohol dependent women. J Subst Abuse Treat. 2017 Sep;80:88-97. doi: 10.1016/j.jsat.2017.07.006. Epub 2017 Jul 8.
PMID: 28755778BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, PhD
Study Record Dates
First Submitted
July 30, 2024
First Posted
October 8, 2024
Study Start
April 4, 2022
Primary Completion
July 1, 2025
Study Completion
July 2, 2025
Last Updated
September 22, 2025
Record last verified: 2024-10